Provided by Tiger Trade Technology Pte. Ltd.

Exagen

7.71
+0.06000.78%
Volume:26.74K
Turnover:206.96K
Market Cap:186.78M
PE:-9.64
High:7.85
Open:7.68
Low:7.68
Close:7.65
52wk High:12.23
52wk Low:2.59
Shares:24.23M
Float Shares:13.99M
Volume Ratio:0.40
T/O Rate:0.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8001
EPS(LYR):-0.9300
ROE:-113.82%
ROA:-14.92%
PB:15.29
PE(LYR):-8.29

Loading ...

Roth Capital Initiates Exagen at Buy With $8 Price Target

MT Newswires Live
·
Jun 25

Exagen Initiated at Buy by Roth Capital

Dow Jones
·
Jun 25

Roth starts Exagen at Buy, notes biomarker testing outperformance

TIPRANKS
·
Jun 25

Exagen Shareholders Approve Directors, Auditor and Pay Package

TIPRANKS
·
Jun 10

Exagen holds annual shareholder meeting, elects two directors

Reuters
·
Jun 10

Exagen says systematic review finds AVISE Lupus test flags 25% of SLE cases missed by standard serology

Reuters
·
Jun 01

Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus

GlobeNewswire
·
Jun 01

Exagen Earnings Call Highlights Growth Amid Headwinds

TIPRANKS
·
May 20

Exagen Earnings Call Highlights Growth Amid Key Risks

TIPRANKS
·
May 13

Exagen Wins Buy Rating on Strong Q1 Beat, Improving Fundamentals and Clear Path to EBITDA Breakeven

TIPRANKS
·
May 12

Exagen: Buy Rating Reiterated as Strong Execution and Growth Outlook Support Unchanged $8 Price Target

TIPRANKS
·
May 12

Exagen Is Maintained at Buy by BTIG

Dow Jones
·
May 12

Exagen’s Risk Profile Remains Unchanged: Stable Yet Persistent Exposures Keep Investors on Alert

TIPRANKS
·
May 12

Analysts Offer Insights on Healthcare Companies: Exagen (XGN) and Liquidia Technologies (LQDA)

TIPRANKS
·
May 12

Exagen reports Q1 EPS (17c), consensus (25c)

TIPRANKS
·
May 12

Exagen backs FY26 revenue view $70M-$73M, consensus $71.27M

TIPRANKS
·
May 12

Exagen Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 11

Exagen Inc. Q1 Revenue USD 17.306 Million Vs. IBES Estimate USD 16.4 Million

Reuters
·
May 11

Exagen beats Q1 revenue estimates, reaffirms 2026 guidance

Reuters
·
May 11

Exagen Q1 FY26 net loss widens to $3.97 million; revenue rises 12% to $17.3 million

Reuters
·
May 11